ゲノミクスにおけるブロックチェーン市場 - 世界の産業規模、シェア、動向、機会、予測：ビジネスモデル別、サービス別、用途別、エンドユーザー別、地域別、競合別、2020年～2030年

ゲノミクスにおけるブロックチェーンの世界市場規模は2024年に10億6,000万米ドルとなり、2030年までのCAGRは11.11%で、予測期間中に力強い成長が予測されています。

ブロックチェーンは、ブロックと呼ばれる単位で取引やデータを安全に記録するデジタル公開台帳です。例えば、2022年にFDAの医薬品評価研究センター（CDER）は37の新規分子実体（NME）を承認しました。35の治療用NMEのうち、12（約34％）が個別化医療連合（PMC）によって個別化医薬品に分類されました。これは、治療成績を改善し副作用を軽減するために、個々の遺伝子、バイオマーカー、分子プロファイルに基づいて治療を調整することが重視されつつあることを強調するものです。各ブロックにはタイムスタンプが押され、前のブロックとリンクしているため、過去にさかのぼって変更することができない不変のチェーンを形成しています。この分散型フレームワークにより、中央機関に依存することなく、相互接続されたシステムのネットワークにデータを分散させることができ、透明性と信頼性が向上します。適切な権限付与によって世界なアクセスが可能になるため、ユーザーは自分のデータを管理し、プライバシーとセキュリティを確保することができます。

市場促進要因

民間企業とベンチャーキャピタルによる投資の増加

主な市場課題

規制上の課題

主要市場動向

技術革新

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のゲノミクスにおけるブロックチェーン市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • ビジネスモデル別（B2Bビジネスモデル、B2Cビジネスモデル、C2Bビジネスモデル）
  • サービス別（ユーティリティトークンとブロックチェーンプラットフォーム）
  • 用途別（データ共有と収益化、データストレージとセキュリティ、自動化された健康保険）
  • エンドユーザー別（製薬・バイオテクノロジー企業、病院・ヘルスケア機関、調査機関、データ所有者など）
  • 地域別
  • 企業別（2024）
• 市場マップ

第6章 北米のゲノミクスにおけるブロックチェーン市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のゲノミクスにおけるブロックチェーン市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のゲノミクスにおけるブロックチェーン市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のゲノミクスにおけるブロックチェーン市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのゲノミクスにおけるブロックチェーン市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品上市
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Oxford Nanopore Technologies Plc
• PacBio（Pacific Biosciences of California Inc.）
• Guardtime Ltd.
• Agilent Technologies Inc.
• Illumina Inc.
• BioRad Laboratories Inc.
• 10x Genomics Inc.
• QIAGEN NV
• Nebula Genomics Inc.
• Thermo Fisher Scientific

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Blockchain in Genomics Market was valued at USD 1.06 Billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 11.11% through 2030. Blockchain is a digital public ledger that securely records transactions and data in units known as blocks. For instane, in 2022, the FDA's Center for Drug Evaluation and Research (CDER) approved 37 new molecular entities (NMEs). Of the 35 therapeutic NMEs, 12-around 34 percent-were classified as personalized medicines by the Personalized Medicine Coalition (PMC). This highlights the growing emphasis on tailoring treatments based on individual genetic, biomarker, or molecular profiles to improve therapeutic outcomes and reduce adverse effects. Each block is timestamped and linked to the previous one, forming an immutable chain that cannot be altered retroactively. This decentralized framework allows data to be distributed across a network of interconnected systems without relying on a central authority, enhancing transparency and reliability. With global accessibility enabled through proper authorization, users maintain control over their data, ensuring privacy and security.

Key Market Drivers

Rising Investment by Private Players and Venture Capitalists

Increased investment provides researchers and innovators with the financial resources needed to explore and develop blockchain solutions tailored for genomics. This funding supports the creation of new platforms, tools, and applications that leverage blockchain's capabilities. For instance, in March 2024, MENADNA Inc., a prominent bioinformatics and genetic testing startup focused on the Middle East and North Africa (MENA) region, announced an exclusive partnership with Nebula Genomics, a leader in personalized genome sequencing. Under this agreement, MENADNA becomes Nebula's exclusive partner in Jordan, Oman, and Iraq. Currently active in the UAE, MENADNA also plans to expand into Saudi Arabia. The collaboration aims to enhance the region's representation in genomic research by combining Nebula's cutting-edge sequencing technology with MENADNA's proprietary bioinformatics platform, addressing a long-standing gap in global genome-wide association studies. Financial support from private players and venture capitalists accelerates the development of blockchain-based solutions for genomics. This leads to quicker advancements in technology, making blockchain more accessible and applicable to genomic research and data management. Funding supports the development of robust and scalable blockchain infrastructure required to handle large volumes of genomic data securely. This infrastructure enables efficient data storage, sharing, and analysis. Investments attract collaboration among stakeholders, including researchers, industry players, technology providers, and healthcare institutions. These partnerships foster a collaborative ecosystem that accelerates blockchain adoption in genomics. Venture capital investment fuels the growth of genomics-focused start-ups that are developing blockchain solutions. These start-ups contribute to the development of new platforms, tools, and applications, increasing the overall demand for blockchain technology. Investment in blockchain technology enables the streamlining of clinical trials, data sharing, and research collaboration. This leads to more efficient and cost-effective research efforts in genomics. Increasing investments from private players and venture capitalists are contributing to the growth of the Blockchain in Genomic Data Management Market. Recent developments in this field, such as strategic partnerships involving pharmaceutical companies and government bodies, as well as investments from venture capital and other stakeholders, indicate the growing acceptance of blockchain platforms for the storage and management of genetic information in the healthcare industry. These collective efforts will significantly drive the market's growth in the years to come.

Key Market Challenges

Regulatory Challenges

The use of blockchain technology in genomics presents several regulatory challenges that need to be addressed to ensure compliance with existing laws and ethical standards. These challenges stem from the unique nature of genomic data, data privacy concerns, data ownership, and the decentralized nature of blockchain. Genomic data is highly sensitive and personal. Regulatory frameworks, such as the General Data Protection Regulation (GDPR) in the European Union, require strict adherence to data privacy principles. Ensuring that individuals provide informed and explicit consent for their data to be stored, shared, and used on the blockchain is a significant challenge. Blockchain's decentralized nature challenges traditional concepts of data ownership. Determining who has control over genomic data stored on the blockchain and how individuals can assert their rights over their data is a regulatory hurdle. Integrating blockchain into existing regulatory frameworks designed for centralized systems can be difficult. Regulators must adapt or create new regulations that accommodate the unique characteristics of blockchain technology.

Key Market Trends

Innovations in Technology

Innovation in blockchain technology within the field of genomics has the potential to significantly boost its demand in the future by addressing existing challenges, enhancing data management, improving research collaboration, and enabling new possibilities for personalized medicine. Innovative blockchain solutions can offer even stronger data security and privacy features, assuaging concerns about the safe storage and sharing of sensitive genomic data. This can encourage more individuals to contribute their data for research and clinical purposes. Blockchain innovations can introduce advanced consent management and data ownership mechanisms. Individuals will have greater control over their genetic data, leading to increased willingness to participate in research initiatives. Innovative blockchain platforms can facilitate secure cross-border data sharing and collaboration among researchers and institutions. This can accelerate the pace of genomics research by allowing global participation and knowledge exchange. As blockchain technology continues to evolve and new innovations emerge, the demand for its integration in genomics is likely to grow. These innovations can address critical concerns, unlock new research opportunities, and ultimately lead to improved patient care, driving the adoption and utilization of blockchain technology in the field of genomics.

Key Market Player

• Oxford Nanopore Technologies Plc
• PacBio (Pacific Biosciences of California Inc.)
• Guardtime Ltd.
• Agilent Technologies Inc.
• Illumina Inc.
• BioRad Laboratories Inc.
• 10x Genomics Inc.
• QIAGEN NV
• Nebula Genomics Inc.
• Thermo Fisher Scientific.

Report Scope:

In this report, the Global Blockchain in Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blockchain in Genomics Market, By Business Model:

• B2B Business Model
• B2C Business Model
• C2B Business Model

Blockchain in Genomics Market, By Service:

• Utility Tokens
• Blockchain Platforms

Blockchain in Genomics Market, By Application:

• Data Sharing & Monetization
• Data Storage & Security
• Automated Health Insurance

Blockchain in Genomics Market, By End User:

• Pharmaceutical & Biotechnology Companies
• Hospitals & Healthcare Providers
• Research Institutes
• Data Owners
• Others

Blockchain in Genomics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Blockchain in Genomics Market.

Available Customizations:

Global Blockchain in Genomics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blockchain in Genomics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Business Model (B2B Business Model, B2C Business Model, and C2B Business Model)
  • 5.2.2. By Service (Utility Tokens and Blockchain Platforms)
  • 5.2.3. By Application (Data Sharing & Monetization, Data Storage & Security, and Automated Health Insurance)
  • 5.2.4. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Providers, Research Institutes, Data Owners, And Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Blockchain in Genomics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Business Model
  • 6.2.2. By Service
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blockchain in Genomics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Business Model
      • 6.3.1.2.2. By Service
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Blockchain in Genomics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Business Model
      • 6.3.2.2.2. By Service
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Blockchain in Genomics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Business Model
      • 6.3.3.2.2. By Service
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Blockchain in Genomics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Business Model
  • 7.2.2. By Service
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blockchain in Genomics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Business Model
      • 7.3.1.2.2. By Service
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Blockchain in Genomics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Business Model
      • 7.3.2.2.2. By Service
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Blockchain in Genomics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Business Model
      • 7.3.3.2.2. By Service
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. France Blockchain in Genomics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Business Model
      • 7.3.4.2.2. By Service
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Blockchain in Genomics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Business Model
      • 7.3.5.2.2. By Service
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Blockchain in Genomics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Business Model
  • 8.2.2. By Service
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Blockchain in Genomics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Business Model
      • 8.3.1.2.2. By Service
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Blockchain in Genomics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Business Model
      • 8.3.2.2.2. By Service
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Blockchain in Genomics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Business Model
      • 8.3.3.2.2. By Service
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Blockchain in Genomics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Business Model
      • 8.3.4.2.2. By Service
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Blockchain in Genomics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Business Model
      • 8.3.5.2.2. By Service
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Blockchain in Genomics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Business Model
  • 9.2.2. By Service
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Blockchain in Genomics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Business Model
      • 9.3.1.2.2. By Service
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Blockchain in Genomics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Business Model
      • 9.3.2.2.2. By Service
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Blockchain in Genomics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Business Model
      • 9.3.3.2.2. By Service
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Blockchain in Genomics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Business Model
  • 10.2.2. By Service
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Blockchain in Genomics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Business Model
      • 10.3.1.2.2. By Service
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Blockchain in Genomics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Business Model
      • 10.3.2.2.2. By Service
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Blockchain in Genomics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Business Model
      • 10.3.3.2.2. By Service
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Oxford Nanopore Technologies Plc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. PacBio (Pacific Biosciences of California Inc.)
• 14.3. Guardtime Ltd.
• 14.4. Agilent Technologies Inc.
• 14.5. Illumina Inc.
• 14.6. BioRad Laboratories Inc.
• 14.7. 10x Genomics Inc.
• 14.8. QIAGEN NV
• 14.9. Nebula Genomics Inc.
• 14.10. Thermo Fisher Scientific

15. Strategic Recommendations

16. About Us & Disclaimer